CMS Seeking Patient Comments On Negotiated Drugs Similar To US FDA’s PFDD Program

Statements on patient experience with the diseases treated by the drugs subject to price negotiation and how they impact their lives are requested; 10 meetings are planned for the fall.

drug negotiation public hearing — • Source: Shutterstock

Patients and others will be able to offer comments on the first group of drugs subject to Medicare price negotiations during a series of listening sessions that seem similar to the US Food and Drug Administration’s Patient-Focused Drug Development program.

The US Centers for Medicare and Medicaid Services on 29 August announced the 10 drugs that will be subject to...